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The phenomenon ofsomatic mutation in expressed Ig Vregion genes has been
well documented in B cells participating in an immune response to several antigens
in the mouse(1-6). Ineach case, theanalyses were carriedoutby capturingindividual
B cells and expanding them in the form ofhybridomas. V region genes expressed
by these hybridomas were then sequenced. Because ofthe similarities oftheir DNA
sequences, particularly at the V/D/J or V/Jjoints, multiple cells from an individual
mouse could often be shown to be derived from a common precursor, and in such
cases, a genealogical relationship between them could be inferred (2, 7, 8). Clonal
expansion is accompanied by the progressive accumulation of point mutations in
the expressed V genes. The rate of this mutational process has been estimated to
be as high as 10- s/bp per cell division (9). It is now clear that somatic hypermuta-
tion is restricted to certain phases ofthe immune response, particularly during the
generation of the memory B cell. During the early primary response and during
the late secondary response, a high rate somatic mutation does not occur (2, 8).
Human B cell lymphomasrepresent particularstages ofB cell differentiation that
have been clonally expanded during the malignant transformation (10). When V
genes of such expanded clones from patients with follicular lymphoma were ana-
lyzed, they were found to be derived from the same original cell and to have under-
gone somatic mutation during clonal evolution (11, 12). The first analysis was done
on a tumor thathad regrown afterinitiallyresponding totreatment byan anti-idiotypic
antibody (13). Analysis ofthese V genes revealed extensive somatic mutations with
an abundance of replacement mutations in complementarity-determining region
2 (CDR2)'. A single mutation was identified as the probable cause for escape of
the tumorfrom the effects ofanti-Id antibody (11). However, it was clear that muta-
tion had preceded any exposure to anti-Id. We proceeded then to analyze the V
genes ofcells derived from a pretreatment specimen ofa second patient with nodular
lymphoma whose tumor responded completely to anti-Id therapy. We found that
this patient's V genes were similarly subject to a mutational process, but that none
ofthe mutations interfered with the reactivity of the anti-idiotypic antibody used
in therapy (12).
The process of somatic mutation in Ig V region genes is evidently a general
phenomenon inhuman follicularlymphoma, since heterogeneous reactivity patterns
with panels of anti-idiotypic antibodies have now been documented in the tumor
' Abbreviation used in this paper: CDR, complementarity-determining region.
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cell populations of a number of cases (14). In these tumors, it is not known if Ig
V gene mutation is an ongoing process or if it happens at a defined time during
the life of the clone and then ceases. However, the fact that V sequences from mul-
tiple individualcells of the tumor are all different from each other implies that muta-
tion is ongoing. It is also unknown if the mutational process was activated by or
selected on by an antigen.
We have now proceeded to study the V,, genes of the two tumors whose V genes
were previously analyzed . Our intention was to determine if the V,. genes had also
mutated, and if so, whether the V and V, within the same cell had mutated at
similar rates and at similar points in time. This comparison was possible because
in each case, the V and V, genes were derived from the same heterohybridoma
cells. We find that light chain genes mutate independently of heavy chain genes and
that certain positions within each gene may represent mutational hot spots.
Materials and Methods
Human Lymphoma Cells and Cell Lines.
￿
For patient PK, tumor cells were isolated from the
peripheral blood during a leukemic phase of follicular small cleaved cell lymphoma (IgM-X)
and fused to NS-1/Ag-4 cells (15). Independent heterohybridomas secreting IgM-?, were de-
rived from the PK tumor, as previously described (16).
For patient CJ, specimens from lymph nodes and spleen were obtained with a follicular
small cleaved cell lymphoma (IgM-x) and processed as previously described (11). Lymphoma
cells were fused to the non-Ig-producing cell line K6H6-B5 (17) and expanded in the form
of independent heterohybridoma clones each secreting IgM-u derived from the CJ tumor
as previously described (17, 18).
Nucleic Acid Isolation.
￿
Cytoplasmic RNA was isolated from heterohybridoma cells after
lysis in 0.5% NP-40 in the presence of 10 mM vanadyl ribonucleoside complex (Bethesda
Research Laboratories, Gaithersburg, MD) in 100 mM NaCl, 50 mM Tris-HCI, pH 7.5,
and 5 MM MgC12, as previously described (11). Poly(A)-containing RNA was isolated by
chromatography on oligo-dT-cellulose (Type 3, Collaborative Research, Lexington, MA) (19).
DNA was extracted from lymphoma tissue and from heterohybridomas by using described
procedures (11).
Construction andScreening of Genomic Library.
￿
DNA from the CJ tumor was digested to com-
pletion with Barn HI (New England Biolabs, Beverly, MA), subjected to electrophoresis on
a preparative agarose gel, and a 7 .5-kb fragment containing the rearranged K gene was ex-
cised. DNA was electroeluted from the gel slice and ligated into the Bam HI site ofthe phage
vector EMBL 3 (20). 106 in vitro packaged recombinants were screened (11) using the Eco
RI fragment containing the human x constant gene region (21) as a probe. Labeling and
hybridization conditions were as previously described (11, 22). Phages that hybridized to the
probe were plaque purified. The 7.5-kb insert was further digested with HindIII (New En-
gland Biolabs) to give a 5 and 2.5-kb fragment. The 2.5-kb piece was subcloned into M13mp19
and sequenced (23).
cDNA Cloning .
￿
The cDNA of the expressed human tumor V, genes was obtained from
individual heterohybridomas by using a rapid method for cloning and sequencingIg V re-
gion genes. In this method, a primer homologous to the constant region is used to initiate
first strand synthesis. The single-stranded cDNA is made double stranded and blunt ended
by successive addition of enzymes to the same tube as described (24). The human x primer
used for cloning VK from patient CJ was 5'CAGATGGCGGGAAGATG 3'(21). The human
), primer used for cloning Vx from patient PK was 5'GTGTGGCCTTGTTGGC 3'(25). The
double-stranded blunt-ended cDNA was ligated directly into the SmaI site ofM13mp19. The
resulting M13 library was lifted onto nitrocellulose filters and screened (26). Hybridization
probes were 32P-labeled first strand cDNA of V, (24) or, when available, a previously ob-
tained cDNA clone labeled with 32P by random hexamer priming (22).LEVY ET AL.
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cDNA Amplification.
￿
In some cases, a modification ofthe polymerase chain reaction (PCR)
(27) was used to amplify cDNA. Double-stranded Vx, cDNA was obtained from PK hetero-
hybridomas K6H6, K6F5, and K5G5, as described above. Amplification of the cDNA was
carried out in a volume of 100 gl amplification buffer (10 mM Tris-HCI, pH 7 .5, 5 mM
M9C12, 1.5 mM dNTPS, 5% DMSO, and 1 mM of primers). The primers used for this
amplification included a sequence homologous to the X constant region gene immediately
5' to the primer used to make the cDNA (5'pCGGGTAGAAGTCACT3') (25), and a sequence
homologous to the leader region of the Vx of the heterohybridoma K6H6. In each cycle of
the PCR, the DNA was heat denatured (100 °C for 5'), quickly chilled on dry ice, centrifuged
for a few seconds, and preincubated at 42°C for 2: 1 U of the large fragment of Escherichia
coli DNA polymerase I (Klenow) (BRL), diluted to 2 U/gl in 10 mM Tris-HCI, pH 7.5, 5
MM MgC12, was added, and the reaction was incubated for 2' at 42°C . After 14 cycles, the
DNA was extracted with phenol/chloroform, then with ether, and was precipitated with eth-
anol. The pellet was dissolved in 50 pl H2O, an equal volume of 2 x amplification buffer was
added, and the amplification reaction was repeated for 15 more cycles. The amplified DNA
was extracted with phenol/chloroform and then with ether and was precipitated with ethanol.
The pellet was dissolved in H2O and subjected to electrophoresis on a 4% Nusieve GTG
(FMC) agarose gel. The major band ofthe expected size was removed, extracted with phenol,
and then with ether, and was precipitated with ethanol. The amplified DNA was ligated into
a blunt-ended M13 vector and isolated in the single-stranded form and sequenced.
Results
Sequences of V, Genes.
￿
Each heterohybridoma captures the heavy and the light
chain Ig genes expressed by an individual tumorcell. Four independent heterohybri-
domas were previously used to obtain the expressed V sequences from lymphoma
cells of a patient (CJ) (11) . In the present study, RNA from the same four hetero-
hybridomas was used as a template for cDNA cloning of the expressed VK genes.
In addition, a 7.5-kb Bam HI restriction fragment (11) containing a portion of the
genomic rearranged V, gene was cloned directly from the tumor biopsy specimen.
These five V,, sequences are shown in Fig. 1. It is evident that these light chain genes
are all derived from members of the same clone of cells because of the extensive
homology of their V and J segments and their identical V/J joints. However, the
sequences all differ from each other. The incomplete G1 sequence differs from clone
1H1 by one nucleotide. Gl was the genomic clone obtained by Bam HI digestion
of tumor DNA. The Bam HI recognition site for this particular V,, gene occurs,
in bases coding for amino acids 57-59 (except for clone 1B11 that has mutated this
site). The genomic sequences that flank the J region of Gl establish that the V re-
gion gene in this tumor has rearranged to Jl (28) (data not shown).
The germ-line version of this V region gene is not known, therefore, all the se-
quences are compared with a consensus sequence. The consensus sequence differs
from theJ1 germ-line gene in five positions, all of which represent silent mutations.
The V region genes differ from each other by a number of silent mutations scattered
throughout the gene. In addition, replacement mutations have occurred both in CDR2
and in CDR3. Two of the replacement mutations in CDR3 happen to be in a poten-
tial glycosylation site in amino acid positions 91-93. This potential glycosylation site
is retained in spite of the replacement mutations, N-XT to N-X-S.
Heterohybridomas obtained from the tumor of patient PK, previously used as
a source of V sequences, were used here to obtain the Va sequences expressed by
the same six individual tumor cells (Fig. 2). In this case, V region cDNA was either478
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FIGURE 1.
￿
Nucleotide sequences of VK genes expressed by tumor CJ. Sequences 2A12, 1H1,
2C12, and 11111 represent cDNA from independent heterohybridomas. Sequence GI was from
a rearranged genomic VK gene cloned directly from the tumor. A consensus sequence is given
along with its amino acid translation numbered according to Kabat et al. (36) in one-letter symbols.
CDR1, CDR2, and CDR3, and theJ region are indicated. Differences from the consensus are
indicated andare boxed when the changes result in an amino acid replacement; dashes indicate
identity.
cloned directly into M13 (24), or was first amplified by the PCR reaction (see Materials
and Methods) and then cloned. Again, we can conclude that the tumor cells ex-
pressing these sequences are all derived from a common precursor cell that rear-
ranged a particular Va gene to a particular J segment with a unique V/J joint. The
Jx used by this tumor is either J2 orJ3, which have an identical sequence (29), and
differs from the consensus sequence at two positions. Once again, no two of these
genes were identical . At least two mutations distinguished each sequence from every
otherone. The sequence derived from heterohybridoma K6F5 was especially different,
with numerous amino acid replacement mutations dispersed throughout the V re-LEVY ET AL.
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￿
Nucleotide sequencesof Vx genes expressed by tumorPK. Sequences were derived
from cDNA from independent heterohybridomas. See legend to Fig. 1 for details.
gion. We have previously reported (12) that theproteinsecreted by this heterohybri-
doma failed to reactwith two out offive anti-idiotypic antibodies. Moreover, hetero-
hybridoma K6F5 exhibited a difference in the size of one of its rearranged X gene
Eco RI restriction fragments compared with the other heterohybridomas. All six
heterohybridomas had in common an 8-kb Eco RI genomic fragment containing
the CX2 and the CO genes (25). Whereas, all other clones had a second rearranged
band of <6 kb, clone K6F5 had asecond rearranged band of >16kb (data not shown).
Thus, the K6F5 cell differed from the other tumor cells at a site outside the V),
coding region as well.
V L and VH Genes Mutate Independently.
￿
The analysis of V,, sequences from the two
lymphomas revealed that the expressed V, genes, like the respective V genes from
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the same cells (11, 12), had accumulated mutations. An attempt was made to relate
the cells within each tumor to each other on the basis of the mutational events that
had occurred in the two genes. A summary of the mutations in each V region gene
is given in Tables I and II. The tables list the amino acid locations of the mutations,
the bases that were changed, their codon positions, and the nature of the mutations
(silent or replacement) as expressed in each heterohybridoma. The total number
of mutations accumulated in each ofthe four sequences analyzed is extremely similar.
Most ofthe mutations occur in the third codon position and are silent. The number
of transversions and transitions in each of the sequences is also very similar. Table
I summarizes the data obtained from V,, and V of each of the heterohybridomas
of patient CJ . It can be seen that two of the hybridomas, 2C12 and 1B11, have a
number of mutations in common, both in V, and V. In addition to the shared
mutations, the two hybridomas accumulated mutations that are unique. The number
of these unique mutations is not always similar for V,, and V in the same hetero-
hybridoma; for example clone 2C12 has a single unique V,, mutation but five
unique V mutations. Similarly, sequences obtained for patient PK (Table II) show
that clone K5G5, with a single unique mutation in VX, accumulated seven such
unique mutations in V . Conversely, clone K6F5 accumulated seven unique mu-
tations in Vx, and only three in V . It is interesting to note that common muta-
tions are mostly silent, whereas many of the unique mutations are replacement mu-
tations.
It is possible to construct separate genealogical trees for these lymphomas for each
V region gene. However, the V, and V trees derived from the same tumor cells
cannot be superimposed . They diverge sometimes at branch point positions; for ex-
ample, clones K4B8, K5B8, and K5G5 stem from the same node in the light chain,
but only clones K4B8 and K5B8 are related in the heavy chain tree (Table I and
Fig. 3). In addition, the trees cannot be superimposed because of differences in the
number of the unique mutations and the distances of the tree branches for the two
chains. This result suggested that the particular cells from which these sequences
were derived were not related in any simple genealogy. Rather, within each set of
sequences, common mutations may have occurred independently, at siteswith a par-
ticular propensity to mutate (hot spots). One mechanism, suggested by Golding et
al. (30) for mutation within Ig genes, is the misalignment of the template during
DNA replication onto neighboring sequences, within the gene, which are almost
exact direct or inverted repeats. The resulting mismatch on the complementary strand
would then be corrected to produce a mutation. These authors have shown that Ig
genes contain a high frequency of direct and inverted repeats, and that many muta-
tions that have been reported could have arisen by such a mechanism. We have,
therefore, examined the DNA sequences surrounding our putative mutations, with
particular attention to the mutations that may have occurred repetitively. In Fig.
4, two examples of direct repeats are shown that could potentially have served as
templates for two different sets of repetitive mutations in the PK VX gene set . A
10-nucleotide stretch beginning in codon 45 is repeated exactly, except for a T to
C substitution downstream beginning in codon 57 . A C to T mutation occurred
at that position in three different cells from this tumor. Similarly, a stretch of nine
nucleotides is repeated in a nested fashion between codons 75 and 80, with a single
C to T change that could have templated that substitution, which occurred in two482
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"Genealogic" trees of V, andV genes expressed by six heterohybridomas obtained
from the tumor of patient PK . The heterohybridomas are displayed as circles and hypothetical
intermediatesand precursors as squares . Distances between clones areproportional to thenumber
of base mutations, as indicated along the lines . Notice that the V, andV trees, derived from
the same cells, cannot be superimposed .
different cells from this tumor. In Fig . 5, examples are shown of inverted repeats
that could have served as templates for six different mutations in the CJVK genes .
The examples shown in Figs . 4 and 5 are the only mutations within our data set
that could have been explained by such a misalignment mechanism. Most ofour
cases of repetitive mutations do not have potential templates within theV region
coding sequence .
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shown . The first in codons 45-48 (boxed)
A TTC CTG AT AGG GTT--//-GGG ATC CCT GAT CGC
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and repeated, except for one base, in
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C to aT(indicatedbythe asterisks), which
results inan identical direct repeat in these
genes (boxed in lower lane). The second re
peat in codons 78-80 of the consensus
(boxed in upper lane) is repeated in codon
75-78, except for one base . Twoofthe Va
genes have mutated aC to aT(indicated
by asterisks), which results in an identical
direct nested repeat in these genes (boxed
A
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TC CAG TC :' GAA
￿
in lower lane). Amino acid numbering was
according to Kabat et al . (36).
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Another mechanism that can explain mutational hot spots involving the transi-
tion of C to T and G to A has been defined by Coulondre et al. (31). They have
shown that when cytosine residues are methylated in the DNA, they can be con-
verted to thymine by spontaneous deamination, resulting in a C to T change on
one DNA strand, which upon replication can lead to a G to A change on the com-
plementary strand. Table III contains a compilation of all the silent (nonselectable)
mutations we observed in the V, and V sequences from the two tumors we ana-
lyzed. The results are compared with those obtained by Li et al. (32), who analyzed
mutations in mammalian pseudogenes, which presumably occurred in the germ-
line over evolutionary time (meiotic mutation). Both sets of data display an excess
of transitions over transversions with a predominance of C to T and G to A substi-
tutions.
F[cUKE 5 . Inverted repeats in the VK gene of Cj
tumor. Two inverted repeats are shown. The first is
present in codons 33-42. The sequence on the left is the
consensus sequence and on the right is the sequence in
two of the VK genes that mutated a T to A and G to
C as indicated by the asterisks. The second inverted re-
peat is present in codons 92-94 and 107-108. The se-
quence on the left is the consensus sequence and on the
right is the sequence in two of the Vh genes that mu-
tated a C to a G as indicated by the asterisks. Amino
acid numbering was according to Kabat et al. (36).
TABLE III
Comparison of Silent Mutations in Human V Regions to Meiotic Mutations in Pseudogenes
All possible base changes are listed, and the observed changes are shown as a percentage after correction
for base composition according to the method of Gojobori et al . (35) and Li et al. (32). Total transitions
are obtained by adding numbers along a diagonal from lower left to upper right and are listed in upper
right; somatic, 667o ; meiotic, 5970 .
* Data from Figures 1, 2, and references 11 and 12. n = 74.
t Data on pseudogenes from Li et al. (32). n = 587 .
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T-A 39 36 T-A
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A - 5.6 3,1 12 A - 4 .7 5.0 9.4
T 3.1 - 3 .1 1 .5 T 4.4 - 8.2 3.3
C 0 28 - 6.6 C 6.5 21 - 4.2
G 23 2 .6 12 - G 21 7 .2 5.3 -LEVY ET AL.
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Discussion
We have previously described extensive somatic mutations in the V genes ex-
pressed in human B cell lymphomas from two patients (11, 12). Here we examined
the sequences of V,, genes expressed by the same cells from which the V genes were
derived. As can be seen in Figs. 1 and 2, it is clear that these V,, genes had also
undergoneextensive somatic mutations. These data suggestthat the mutational rate
is high in these tumors and similar for both V,,and V genes, that silent mutations
predominate, and that the underlying mutational process may involve hot spots.
Somatic mutation occurs at a high rate in Ig V region genes expressed by B cells
participating in an immune response. Most of the documented examples represent
situations in which inbred mice respond to a particular antigen by producing an
immune response dominated by a unique idiotype. These recurrent idiotypes are
encoded by particular germ-line genes for both the V and the V,. and, in some
cases, use particular D andJ segments (1-4, 6). Thus, the mutations occurring in
these V region genes during clonal expansion can be determined precisely by refer-
ence to the known germ-line gene sequences. Some general conclusions from these
experiments follows. (a) Both V,, and V genes in the same cells are subject to the
mutational process. (b) Mutations that result in amino acid replacements tend to
be found in CDR regions and can be correlated with improved antigen binding (1,
4, 6, 34). The occasional findingof identical replacement mutations in independent
clones can thus be explained by the positive selective force of antigen. (c) Silent mu-
tations are found as frequently in framework regions as in CDR regions and are
not apparently under selective pressure. Identical silent mutations found in inde-
pendent clones have been suggested to represent mutational hot spots (1, 4) .
Genealogic trees have been constructed based on multiple identical V gene muta-
tions shared by individual B cell clones (2, 7, 8) . Such trees are obviouslydependent
on the assumption that the cells bearingthe sequences originatefrom the same cell,
which underwent rearrangement of a single functional VH and V,, gene. For immune
responses dominated by the use of particular V gene segments, such a demonstra-
tion is not always easy because multiple different B cells may use the identical gene
segments. In the case of spontaneous human B cell tumors, it is usually clear that
a single clone of cellsis involved. The individual members of the tumoruse not only
the same Vgene segments but also show identical V/D/J and V/Jjoints. In addition,
the follicular lymphomas (the type of tumor analyzed here) all have a specific chro-
mosomal translocation involving a gene called bcl-2 on chromosome 18 and the Ig
locus on the inactive allele of chromosome 14 (33). The analysis ofevolution within
these malignant human B cell clones is somewhat disadvantaged by the lack of
information about the germ-line versions of the V genes in question, although the
germ-line D andJ segments are known. For this reason, one must use a consensus
sequence as the frameofreference for the assignment of mutations. Our prioranal-
yses of VH sequences from two different tumors proposed a genealogic relationship
between the members of each clone (11, 12). The current data on V,, sequences from
these same cells can also be arranged into a plausible genealogic relationship for
each tumor. However, no simple genealogic relationship can be made between the
cells of each tumor that takes both the V,, and V sequences into account. Since
these tumors contained >10" cells at the time of sampling, it is not surprising that
the evolutionary relationship among a small number ofcells is difficult to establish.486
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Also, the genealogic trees that can be constructed from the data have a preponder-
ance ofsilent mutations at the branch points and coding mutations at the extremi-
ties. Ifthe clonehad indeed followed such a tree ofevolution, it is difficult toexplain
why branches should occur in the absence ofselective forces. Rather, it seems more
likely that the repetitive silent mutations found both within the V, and the V se-
quences are the result of sites that are especially prone to mutation, i.e., hot spots.
Berekand Milstein (4) found multiple examples ofrepetitive silent mutationsamong
independentB cell clones respondingto the antigen phenyloxazolone. For instance,
in their data, as many as fourpairsofidentical silent changes were observed among
19 V sequences derived from different mice. Their statistical analysis showed this
pattern ofrepeats to be exceedingly unlikely tooccurby chance (;b = 0.011). By com-
parison, we observeasmany as five double and two triple repeats ofsilent mutations
out ofsix V,, sequences from the PK tumor clone (Fig. 2 and Table II). Moreover,
our data argues notjust forhot spots but for hot specific events. That is, there must
be a propensity to change not just a certain position but to make certain specific
substitutions. One mechanism that has been proposed for the generation ofmuta-
tions in IgV genes involves the misalignment ofthe DNA template during replica-
tion due to neighboring direct or inverted repeat sequences that differ only slightly
from the sequence beingcopied (30). Such amechanism specifiesnot only theposi-
tion ofmutations, but also the specific change. In addition, it provides an explana-
tion for multiple alterations ofa gene as a result ofa single mutational event. That
is, the template being used can have several differences from the homologous se-
quence, and each ofthese can be simultaneously copied onto the new DNA strand.
Indeed, potential templates were found within the coding region sequences for sev-
eral of the repetitive silent mutations in our data (Figs. 4 and 5). In Fig. 5, an ex-
ample of two substitutions within the same inverted repeat is shown. However, we
found such repeats for only a minority ofthe hot spots we observed. It is possible
that templates for more of the hot spots did exist further upstream or downstream
beyond the coding regions that we analyzed here.
Additional clues about a possible mechanism ofmutation inthese cells come from
an analysisofthe chemical nature ofthe base substitutions. Ifmutation represented
a random incorporation of inappropriate bases, transversions (purine H pyrimi-
dine) should be twice as frequent as transitions (purine H purine, pyrimidine H
pyrimidine). In fact, this ratio is almost exactly reversed (Table III). On closer in-
spection, this excess oftransitions is accounted for by the relatively high frequency
ofthe changes ofC to Tand ofG to A. The same pattern has been noted in muta-
tions in a number ofdifferent pseudogenes over the evolution of species (32). The
conversion ofC to T can occur in DNA by deamination of methylated C residues.
Indeed this reaction has been implicated in a mutational hot spot in the Lac Z gene
in E. coli (31). If such a change occurred on the antisense strand, it would result
in a change of G to A on the sense strand after subsequent replication. The possi-
bility exists, therefore, that the mutational process could be targeted tocertain posi-
tions by specific methylation events.
Mechanisms of mutation such as those mentioned above could, in principle, be
tested by constructing substrate genes. Such genes containing specific internal tem-
plates or specific methylated cytosine residues could thenbe introduced into B cells
undergoing mutations. B Cell lines at appropriate stages ofdifferentiation, for in-LEVY ET AL.
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stance, those participating in the late primary or memory response to an antigen,
could be used. Based on the data reported here, cell lines from patients with follic-
ular lymphoma might also be suitable. The creation of such cell lines, therefore,
remains high priority for the future.
Summary
The genes coding for the Ig light chains expressed in two cases ofhuman follicular
lymphoma were cloned and sequenced. In each case, multiple independent isolates
of the tumor population were compared. Although each tumor represented a single
clone of B cells with a unique V/J joint, different cells within each tumor had accu-
mulated multiple point mutations in the V gene during clonal expansion . Most of
the mutations observed were silent, but some resulted in amino acid replacements.
Identical silent mutations were often observed in independent isolates ofeach tumor.
By combining the current data with V sequences obtained previously from the
same cells, it was apparent that the repetitive silent mutations could not be explained
solely by a genealogic tree. Such mutations could represent hot spots whose ten-
dency to mutate may be influenced by neighboring DNA sequences or by the meth-
ylation of specific cytosine residues.
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